Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes. 2013

Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Poland. Electronic address: katarzynasiewko@go2.pl.

BACKGROUND We analyzed the relationship between fasting plasma glucose (FPG), the presence of autoantibodies, first phase of insulin secretion and insulin resistance in the first degree relatives of patients with type 1 diabetes. METHODS The group studied consisted of 90 healthy relatives, divided into two groups: "high-normal" FPG group (≥88mg/dl) and "low-normal" FPG group (<88/mg/dl). All subjects underwent an intravenous glucose tolerance test, and the 1st phase insulin response (FPIR) and FPIR-to-HOMA-IR-ratio were calculated. Additionally, islet autoantibodies (GADA, IAA and IA-2A) were determined by radioimmunoassays. RESULTS The subjects with "high-normal" FPG were older (p=0.0009), had higher BMI (p<0.0001) and lower HOMA%B (p=0.0004), FPIR (p=0.006) and FPIR-to-HOMA-IR-ratio (p=0.004) in comparison with the "low-normal" FPG group. Autoantibodies were present in 40.9% and in 21.7% of the subjects with "high-normal" and "low-normal" FPG, respectively. In the "high-normal" FPG group, FPG correlated positively with GADA (r=0.31, p=0.04), and HOMA-IR (r=0.19, p=0.02), and negatively with HOMA%B (r=-0.36, p=0.001), whereas FPIR correlated positively with HOMA%B (r=0.55, p=0.0001) and BMI (r=0.30, p=0.04). After an adjustment for BMI, the difference in FPIR between the "high-normal" and "low-normal" FPG groups remained significant (p=0.025), whereas the difference in FPIR-to-HOMA-IR-ratio became insignificant. CONCLUSIONS Our results suggest that taking into account the impact of age and BMI on insulin sensitivity, it would be expected that the relatives of patients with type 1 diabetes with "high-normal" glucose levels would become gradually unable to compensate for increasing insulin resistance.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
December 2000, Diabetes,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
May 2003, Medical science monitor : international medical journal of experimental and clinical research,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
July 1999, Annals of internal medicine,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
January 1997, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
June 2010, Diabetes research and clinical practice,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
January 2010, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
June 2007, Annales d'endocrinologie,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
September 1995, Immunology letters,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
May 2015, Hypertension research : official journal of the Japanese Society of Hypertension,
Katarzyna Siewko, and Anna Popławska-Kita, and Beata Telejko, and Rafał Maciulewski, and Anna Zielińska, and Agnieszka Nikołajuk, and Maria Górska, and Małgorzata Szelachowska
January 1998, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!